Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis
Clinical trial NCT03828344 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT03828344
- Sponsor
- Baylx Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2027-12-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.